# LAB (Standard Biotools Inc.) - SEC EDGAR Financial Statements

> Standard Biotools Inc. reported $84.43M in revenue and net income of $133.1M for the trailing twelve months ended September 30, 2026 (down 0.9% year over year), with a 52.2% gross margin and a -97.5% operating margin.

- Canonical: https://convexityos.com/fundamentals/LAB
- Markdown: https://convexityos.com/fundamentals/LAB.md
- SEC CIK: 0001162194
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:42 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001162194&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $84.43M | -0.9% YoY |
| Operating Income | TTM | -$82.30M | -97.5% margin |
| Net Income | TTM | $133.1M | 157.6% net margin |
| Diluted EPS | TTM | $0.34 | Split-adjusted |
| Free Cash Flow | TTM | -$65.65M | -77.8% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $461.1M | Total debt: $26.53M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $85.33M | $91.01M | $106.3M | $97.95M | $130.6M | $138.1M | $117.2M | $113.0M | $101.9M | $104.4M |
| Cost of Revenue | $42.79M | $46.12M | $55.89M | $60.90M | -- | -- | $52.96M | $51.31M | $49.95M | $300K |
| **Gross Profit** | $42.54M | $44.88M | $50.45M | $37.05M | -- | -- | $64.28M | $61.65M | $51.98M | $58.44M |
| Research & Development | $25.99M | $28.83M | $25.95M | $37.38M | $37.94M | $36.46M | $31.64M | $30.03M | $30.83M | $38.41M |
| Selling, General & Admin | $109.9M | $103.1M | $87.54M | $102.3M | $98.89M | $97.90M | $84.48M | $79.78M | $79.52M | $93.21M |
| Total Operating Expenses | $152.8M | $172.4M | $127.0M | $153.3M | $198.0M | $189.2M | $169.1M | $161.1M | $110.3M | $131.6M |
| **Operating Income** | -$110.2M | -$127.5M | -$76.60M | -$116.2M | -$67.46M | -$51.04M | -$51.84M | -$48.16M | -$58.36M | -$73.19M |
| **EBITDA** | -$101.0M | -$115.0M | -$63.93M | -$103.8M | -$64.24M | -$47.02M | -$47.23M | -$42.79M | -$50.95M | -$66.45M |
| Interest Income | $9.18M | $20.20M | $5.57M | $2.23M | -- | -- | -- | -- | -- | -- |
| Interest Expense | -- | -- | $4.57M | $4.33M | $3.82M | $3.57M | $4.28M | $13.89M | $5.82M | $5.82M |
| Income Before Tax | -$96.70M | -$90.40M | -$74.20M | -$192.9M | -$63.66M | -$54.10M | -$66.70M | -$61.42M | -$63.80M | -$80.18M |
| Income Tax Expense | -$37.88M | $542K | $452K | -$2.83M | -$4.42M | -$1.08M | -$1.92M | -$2.41M | -$3.26M | -$4.19M |
| **Net Income** | -$74.90M | -$138.9M | -$74.66M | -$190.1M | -$59.24M | -$53.02M | -$64.79M | -$59.01M | -$60.53M | -$75.98M |
| Basic EPS | -$0.20 | -$0.52 | -$0.94 | -$2.43 | -$0.78 | -$0.74 | -$0.97 | -$1.49 | -$1.84 | -$2.62 |
| **Diluted EPS** | -$0.20 | -$0.52 | -$0.94 | -$2.43 | -$0.78 | -$0.74 | -$0.97 | -$1.49 | -$1.84 | -$2.62 |
| Basic Shares Outstanding | 381.6M | 353.2M | 79.2M | 78.3M | 75.8M | 72.0M | 66.8M | 39.7M | 33.0M | 29.0M |
| Diluted Shares Outstanding | 381.6M | 353.2M | 79.2M | 78.3M | 75.8M | 72.0M | 66.8M | 39.7M | 33.0M | 29.0M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $19.39M | $20.10M | $21.15M | $23.80M | $19.55M | $21.76M | $20.22M | $24.78M |
| Cost of Revenue | $8.56M | $9.57M | $9.84M | $12.41M | $10.07M | $11.13M | $9.17M | $13.42M |
| **Gross Profit** | $10.83M | $10.54M | $11.31M | $11.38M | $9.48M | $10.63M | $11.05M | $11.36M |
| Research & Development | $2.08M | $1.98M | $2.12M | $7.97M | $6.36M | $6.22M | $5.44M | $7.04M |
| Selling, General & Admin | $16.84M | $16.39M | $18.61M | $25.34M | $26.59M | $28.11M | $29.82M | $27.32M |
| Total Operating Expenses | $30.60M | $35.92M | $23.80M | $36.03M | $42.42M | $36.33M | $38.02M | $37.44M |
| **Operating Income** | -$19.77M | -$25.39M | -$12.50M | -$24.64M | -$32.94M | -$25.70M | -$26.97M | -$26.08M |
| **EBITDA** | -$18.57M | -$24.11M | -$11.09M | -$23.35M | -$31.42M | -$22.52M | -$23.70M | -$22.94M |
| Interest Income | $4.88M | $4.61M | $3.51M | $1.68M | $2.13M | $2.45M | $2.91M | $3.90M |
| Income Before Tax | -$14.95M | -$21.43M | -$14.62M | -$22.03M | -$32.90M | -$18.28M | -$23.49M | -$26.90M |
| Income Tax Expense | $27K | $90K | $11K | -$35.93M | -$1.22M | -$609K | -$119K | $272K |
| **Net Income** | $13.48M | -$26.76M | $127.1M | $19.28M | -$34.69M | -$33.46M | -$26.03M | -$34.07M |
| Basic EPS | $0.03 | -$0.07 | $0.33 | -- | -$0.09 | -$0.09 | -$0.07 | -- |
| **Diluted EPS** | $0.03 | -$0.07 | $0.33 | -- | -$0.09 | -$0.09 | -$0.07 | -- |
| Basic Shares Outstanding | 393.6M | 390.9M | 388.2M | -- | 382.6M | 380.5M | 378.2M | -- |
| Diluted Shares Outstanding | 393.6M | 390.9M | 388.2M | -- | 382.6M | 380.5M | 378.2M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $120.9M | $166.7M | $51.70M | $81.31M | $28.45M | $68.52M | $21.66M | $95.40M | -- | $58.06M |
| Short-Term Investments | $66.71M | $126.1M | $63.19M | $84.47M | $0 | $0 | $36.98M | $0 | -- | $5.08M |
| **Cash & Short-Term Investments** | $187.6M | $292.9M | $114.9M | $166.8M | $29.47M | $69.54M | $60.71M | $95.40M | -- | $63.14M |
| Accounts Receivable, Net | $13.43M | $14.74M | $19.66M | $17.28M | $18.32M | $25.42M | $18.98M | $16.65M | -- | $15.05M |
| Inventory | $19.98M | $20.74M | $20.53M | $21.47M | $20.82M | $19.69M | $13.88M | $13.00M | -- | $15.09M |
| **Total Current Assets** | $454.3M | $375.9M | $158.2M | $208.8M | $72.07M | $117.7M | $96.10M | $127.1M | $94.95M | $94.80M |
| Property, Plant & Equipment, Net | $19.27M | $22.77M | $24.19M | $25.65M | $28.03M | $17.53M | $8.06M | $8.82M | -- | $12.30M |
| Goodwill | -- | $111.3M | $106.3M | $106.3M | $106.4M | $106.6M | $104.1M | $104.1M | -- | $104.1M |
| Intangible Assets | -- | $28.95M | $1.40M | $12.60M | $27.93M | $40.21M | $46.20M | $57.40M | -- | $68.60M |
| Long-Term Investments | $25.70M | $0 | -- | -- | -- | -- | -- | -- | -- | -- |
| Other Non-Current Assets | $3.15M | $3.55M | $2.29M | $3.11M | $3.69M | $4.68M | $5.49M | $6.21M | $7.75M | $7.54M |
| **Total Non-Current Assets** | $113.5M | $236.5M | $164.9M | $181.5M | $203.1M | $207.1M | $168.7M | $176.5M | $192.8M | $192.6M |
| **Total Assets** | $567.8M | $612.3M | $323.1M | $390.3M | $275.2M | $324.8M | $264.8M | $303.6M | $287.7M | $287.4M |
| Accounts Payable | $5.41M | $5.05M | $9.24M | $7.91M | $10.60M | $9.22M | $5.15M | $4.03M | -- | $4.21M |
| Deferred Revenue (Current) | $38.95M | $10.27M | $11.61M | $10.79M | $11.95M | $13.47M | $11.80M | $11.46M | -- | $10.24M |
| **Total Current Liabilities** | $108.3M | $65.89M | $109.3M | $43.44M | $49.57M | $54.25M | $32.82M | $37.58M | -- | $33.47M |
| Long-Term Debt | -- | $299K | $63.51M | $64.89M | -- | -- | -- | -- | -- | $195.2M |
| Deferred Revenue (Non-Current) | $3.50M | $32.67M | $3.52M | $3.82M | $5.97M | $7.99M | $8.17M | $6.33M | -- | $4.96M |
| Other Non-Current Liabilities | $1.22M | $1.06M | $1.06M | $961K | $882K | $1.33M | $573K | $1.85M | -- | $5.83M |
| **Total Non-Current Liabilities** | $35.16M | $74.73M | $50.54M | $117.1M | $131.1M | $131.5M | $78.38M | $193.9M | -- | $222.9M |
| **Total Liabilities** | $143.5M | $140.6M | $159.9M | $160.5M | $180.6M | $185.7M | $111.2M | $231.5M | $256.4M | $256.4M |
| **Total Debt (incl. Leases)** | $30.53M | $33.00M | $98.21M | $102.7M | $40.60M | $41.15M | $6.16M | -- | -- | $195.2M |
| Common Stock | $404K | $396K | $83K | $80K | $77K | $75K | $70K | $49K | -- | $39K |
| Retained Earnings | -$1.26B | -$1.19B | -$1.00B | -$926.1M | -$736.0M | -$676.8M | -$623.6M | -$558.9M | -$499.8M | -$500.2M |
| Accumulated Other Comp. Income | -$1.49M | $1.23M | -$2.22M | -$1.90M | -$907K | $112K | -$582K | -$687K | -- | -$574K |
| **Total Stockholders' Equity** | $424.3M | $471.7M | -$148.1M | -$81.47M | $94.60M | $139.1M | $153.6M | $72.12M | $31.29M | $30.93M |
| Total Equity | $424.3M | $471.7M | -$148.1M | -$81.47M | $94.60M | $139.1M | $153.6M | $72.12M | $31.29M | $30.93M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $267.5M | $270.0M | $265.8M | $120.9M | $129.4M | $158.6M | $150.9M | $166.7M |
| Short-Term Investments | $193.6M | $206.7M | $189.4M | $66.71M | $65.48M | $78.47M | $107.2M | $126.1M |
| **Cash & Short-Term Investments** | $461.1M | $476.7M | $455.2M | $187.6M | $194.9M | $237.1M | $258.1M | $292.9M |
| Accounts Receivable, Net | $12.98M | $15.75M | $16.64M | $13.43M | $13.54M | $14.61M | $35.48M | $14.74M |
| Inventory | $17.62M | $17.10M | $18.59M | $19.98M | $25.42M | $24.17M | $42.12M | $20.74M |
| **Total Current Assets** | $497.3M | $516.9M | $521.5M | $454.3M | $472.4M | $506.0M | $344.0M | $375.9M |
| Property, Plant & Equipment, Net | $13.24M | $15.30M | $17.10M | $19.27M | $20.74M | $22.68M | $43.59M | $22.77M |
| Goodwill | -- | -- | -- | -- | -- | -- | $111.7M | $111.3M |
| Intangible Assets | -- | -- | -- | -- | -- | -- | $28.06M | $28.95M |
| Long-Term Investments | $98.24M | $67.28M | $71.36M | $25.70M | $19.48M | -- | -- | $0 |
| Other Non-Current Assets | $3.19M | $3.26M | $3.39M | $3.15M | $3.52M | $3.68M | $6.51M | $3.55M |
| **Total Non-Current Assets** | $138.0M | $110.4M | $117.7M | $113.5M | $67.20M | $50.93M | $235.6M | $236.5M |
| **Total Assets** | $635.3M | $627.2M | $639.1M | $567.8M | $539.6M | $557.0M | $579.6M | $612.3M |
| Accounts Payable | $3.45M | $9.55M | $8.01M | $5.41M | $6.62M | $7.33M | $11.78M | $5.05M |
| Deferred Revenue (Current) | $8.81M | $9.14M | $9.98M | $38.95M | $40.11M | $40.17M | $12.76M | $10.27M |
| **Total Current Liabilities** | $51.02M | $56.80M | $42.20M | $108.3M | $108.0M | $98.02M | $56.24M | $65.89M |
| Long-Term Debt | -- | -- | -- | -- | -- | -- | -- | $299K |
| Deferred Revenue (Non-Current) | $3.10M | $3.15M | $3.01M | $3.50M | $2.37M | $2.79M | $32.55M | $32.67M |
| Other Non-Current Liabilities | $1.12M | $1.11M | $4.44M | $1.22M | $1.20M | $1.25M | $3.49M | $1.06M |
| **Total Non-Current Liabilities** | $28.56M | $30.45M | $35.79M | $35.16M | $32.01M | $34.41M | $68.77M | $74.73M |
| **Total Liabilities** | $79.58M | $87.25M | $77.99M | $143.5M | $140.0M | $132.4M | $125.0M | $140.6M |
| **Total Debt (incl. Leases)** | $26.53M | $27.79M | $29.19M | $30.53M | $27.09M | $28.32M | $31.23M | $33.00M |
| Common Stock | $413K | $410K | $408K | $404K | $401K | $400K | $397K | $396K |
| Retained Earnings | -$1.15B | -$1.16B | -$1.13B | -$1.26B | -$1.28B | -$1.25B | -$1.21B | -$1.19B |
| Accumulated Other Comp. Income | $354K | $1.18M | -$511K | -$1.49M | -$477K | -$1.93M | $1.17M | $1.23M |
| **Total Stockholders' Equity** | $555.8M | $540.0M | $561.1M | $424.3M | $399.7M | $424.5M | $454.6M | $471.7M |
| Total Equity | $555.8M | $540.0M | $561.1M | $424.3M | $399.7M | $424.5M | $454.6M | $471.7M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$74.90M | -$138.9M | -$74.66M | -$190.1M | -$59.24M | -$53.02M | -$64.79M | -$59.01M | -$60.53M | -$75.98M |
| Depreciation & Amortization | $9.26M | $12.52M | $12.67M | $12.45M | $3.22M | $4.01M | $4.61M | $5.37M | $7.41M | $6.74M |
| Stock-Based Compensation | $29.61M | $31.73M | $13.12M | $14.88M | $16.10M | $14.45M | $11.39M | $11.02M | $9.09M | $13.86M |
| Change in Receivables | -$1.36M | $8.97M | -$2.99M | $1.06M | $6.73M | -$7.63M | -$2.08M | -$1.79M | -$554K | $10.52M |
| Change in Inventory | -$11.52M | -$9.88M | -$4.91M | -$8.47M | -$4.78M | -$8.64M | -$3.05M | $398K | $4.16M | -$3.39M |
| Change in Payables | $2.44M | -$12.97M | $1.62M | -$2.78M | $1.28M | $3.36M | $787K | -$294K | $585K | -$2.27M |
| **Operating Cash Flow** | -$74.34M | -$143.5M | -$43.29M | -$89.37M | -$44.06M | -$15.42M | -$35.21M | -$25.20M | -$24.10M | -$39.14M |
| Capital Expenditure | -$8.30M | -$8.36M | -$2.83M | -$3.83M | -$13.26M | -$12.72M | -$2.53M | -$372K | -$1.57M | -$5.07M |
| **Free Cash Flow** | -$82.65M | -$151.8M | -$46.12M | -$93.19M | -$57.33M | -$28.13M | -$37.74M | -$25.57M | -$25.66M | -$44.20M |
| Acquisitions, Net | $0 | -$1.39M | $0 | -- | $0 | -$5.15M | $0 | $0 | -- | $0 |
| Purchases of Investments | -$6.86M | $0 | $0 | -- | $0 | $0 | -$62.37M | -$1.45M | -$6.28M | -$38.59M |
| Sales & Maturities of Investments | -- | -- | -- | -- | -- | -- | $25.60M | $6.54M | $25.55M | $86.43M |
| **Investing Cash Flow** | $27.41M | $363.2M | $20.24M | -$88.13M | -$11.95M | $39.98M | -$39.30M | $4.72M | $17.66M | $45.10M |
| Common Stock Issued | -- | -- | -- | -- | $0 | $20.23M | $0 | $59.47M | $28.79M | $0 |
| Share Repurchases | $0 | -$40.49M | -$5.41M | -$563K | $0 | -- | -- | -- | -- | -- |
| **Financing Cash Flow** | $570K | -$102.6M | -$6.81M | $230.8M | $15.96M | $20.86M | $2.79M | $57.66M | $29.00M | $116K |
| **Net Change in Cash** | -$45.52M | $116.3M | -$29.82M | $52.86M | -$40.07M | $45.80M | -$71.67M | $37.34M | $23.01M | $5.93M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | $13.48M | -$26.76M | $127.1M | $19.28M | -$34.69M | -$33.46M | -$26.03M | -$34.07M |
| Depreciation & Amortization | $1.20M | $1.27M | $1.41M | $1.29M | $1.52M | $3.18M | $3.27M | $3.14M |
| Stock-Based Compensation | $3.72M | $4.05M | $8.82M | $5.74M | $8.47M | $6.39M | $9.01M | $7.47M |
| Change in Receivables | $2.65M | $1.25M | -$1.86M | $6.73M | -$5.79M | -$276K | -$2.02M | $6.70M |
| Change in Inventory | -$334K | $1.25M | $1.94M | -$1.17M | -$1.80M | -$4.73M | -$3.82M | $5.03M |
| Change in Payables | -$5.96M | $1.67M | -$1.22M | $653K | $946K | $1.42M | -$578K | -$88K |
| **Operating Cash Flow** | -$6.16M | -$10.31M | -$46.60M | -$1.19M | -$22.20M | -$20.67M | -$30.28M | -$14.06M |
| Capital Expenditure | $0 | -$344K | -$570K | -$476K | -$886K | -$1.89M | -$5.05M | -$3.38M |
| **Free Cash Flow** | -$6.16M | -$10.65M | -$47.17M | -$1.67M | -$23.09M | -$22.55M | -$35.34M | -$17.44M |
| Purchases of Investments | $0 | -$2.0K | -$837K | -$6.86M | $0 | $0 | $0 | -- |
| **Investing Cash Flow** | $4.83M | $14.41M | $191.1M | -$8.04M | -$6.68M | $27.50M | $14.62M | $25.73M |
| Share Repurchases | -- | -- | -- | $0 | $0 | $0 | $0 | $0 |
| **Financing Cash Flow** | -$598K | -$138K | -$40K | $620K | -$112K | $108K | -$46K | -$54.52M |
| **Net Change in Cash** | -$2.55M | $4.25M | $144.6M | -$8.71M | -$29.20M | $7.73M | -$15.35M | -$43.12M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 49.9% | 49.3% | 47.4% | 37.8% | -- | -- | 54.8% | 54.6% | 51.0% | 55.9% |
| **Operating Margin** | -129.2% | -140.1% | -72.0% | -118.6% | -51.7% | -36.9% | -44.2% | -42.6% | -57.3% | -70.1% |
| **Net Profit Margin** | -87.8% | -152.6% | -70.2% | -194.1% | -45.4% | -38.4% | -55.3% | -52.2% | -59.4% | -72.8% |
| Return on Equity (ROE) | -17.7% | -29.4% | -- | -- | -62.6% | -38.1% | -42.2% | -81.8% | -195.7% | -142.7% |
| Return on Assets (ROA) | -13.2% | -22.7% | -23.1% | -48.7% | -21.5% | -16.3% | -24.5% | -19.4% | -21.1% | -24.8% |
| Current Ratio | 4.19x | 5.70x | 1.45x | 4.81x | 1.45x | 2.17x | 2.93x | 3.38x | 2.83x | 3.28x |
| Quick Ratio | 4.01x | 5.39x | 1.26x | 4.31x | 1.03x | 1.81x | 2.50x | 3.04x | 2.38x | 2.60x |
| Debt to Equity | 0.07x | 0.07x | -- | -- | 0.43x | 0.30x | 0.04x | -- | 6.31x | -- |
| **Revenue Growth (YoY)** | -6.2% | -14.4% | +8.6% | -25.0% | -5.5% | +17.8% | +3.8% | +10.8% | -2.4% | -8.9% |
| Gross Profit Growth (YoY) | -5.2% | -11.0% | +36.2% | -- | -- | -- | +4.3% | +18.6% | -11.0% | -48.9% |
| 5Y Revenue / Share Growth | -88.3% | -85.3% | -52.8% | -59.5% | -52.1% | -52.0% | -58.1% | +2.0% | +30.7% | +49.9% |
| 10Y Revenue / Share Growth | -94.4% | -93.9% | -51.9% | -47.1% | -28.3% | -89.2% | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 52.2% | 50.5% | 49.6% | 49.9% | 49.3% | 50.8% | 50.1% | 50.5% |
| **Operating Margin** | -97.5% | -112.8% | -111.0% | -129.2% | -129.4% | -118.7% | -122.8% | -124.7% |
| **Net Profit Margin** | 157.6% | 100.4% | 90.7% | -87.8% | -148.6% | -135.6% | -148.2% | -120.9% |
| Return on Equity (ROE) | 23.9% | 15.7% | 13.9% | -17.7% | -32.1% | -28.4% | -29.2% | -29.4% |
| Return on Assets (ROA) | 20.9% | 13.5% | 12.2% | -13.2% | -23.8% | -21.6% | -22.9% | -22.7% |
| Current Ratio | 9.75x | 9.10x | 12.36x | 4.19x | 4.38x | 5.16x | 6.12x | 5.70x |
| Quick Ratio | 9.40x | 8.80x | 11.92x | 4.01x | 4.14x | 4.92x | 5.37x | 5.39x |
| Debt to Equity | 0.05x | 0.05x | 0.05x | 0.07x | 0.07x | 0.07x | 0.07x | 0.07x |
| **Revenue Growth (YoY)** | -0.9% | -7.6% | +4.6% | -4.0% | -11.5% | -3.2% | -55.6% | -12.1% |
| Gross Profit Growth (YoY) | +14.2% | -0.9% | +2.3% | +0.2% | -21.8% | +2.4% | -54.3% | -15.0% |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
